Laurence De Moerlooze

EVP & Chief Medical Officer at Bavarian Nordic

Mrs. De Moerlooze joined Bavarian Nordic in April 2020 from Takeda Vaccines, where she served as Vice President and Global Program Lead for vaccines against Zika virus and Norovirus. Prior to joining Takeda, she worked at GlaxoSmithKline (GSK) for more than 15 years, holding various leading roles in medical affairs and vaccine development working with numerous life-saving vaccines including Rabipur/Rabavert and Encepur. Mrs. De Moerlooze holds a PhD.

Org chart

Manager

Paul Chaplin

President & CEO

Peers

Tommi Kainu

Executive Vice President, Chief Business Officer

Henrik Juuel

Executive Vice President, Chief Financial Officer

Jean-Christophe May

EVP & Chief Commercial Officer

Reports

Bernard Hoet

Vice President Of Medical Strategy At Bavarian Nordic

Anna Stahl

Head Of Clinical Safety And Pharmacovigilance, Senior Director

Rebecca Abblitt

Director, Clinical Programs

Steven Stoddard Ms

Director Of Epidemiology, Clinical Strategy

Timeline

EVP & Chief Medical Officer
Current role

View in org chart